Chemomab Therapeutics Ltd
NASDAQ:CMMB
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Price:
1.6082
USD
9.4%
Market Closed
Market Cap:
$11.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cruzados SADP
SGO:CRUZADOS
|
CL |
Chemomab Therapeutics Ltd
PP&E Gross
Last Value
3 Years CAGR
3Y CAGR
5 Years CAGR
5Y CAGR
10 Years CAGR
10Y CAGR
|
See Also
Chemomab Therapeutics Ltd
PP&E Gross Peer Comparison
Chemomab Therapeutics Ltd
Glance View
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
CMMB
Intrinsic Value
1.4396
USD
Overvaluation 10%
